
The Silent Threat of Bleeding
The Hypertension and Antithrombotic Risk Assessment (HAS-BLED) score is a crucial tool for assessing the risk of bleeding in patients receiving anticoagulant therapy. However, traditional methods of calculating and applying the HAS-BLED score often lead to inconsistencies and delays in treatment decisions, increasing the risk of bleeding complications.

The Devastating Consequences of Bleeding
Bleeding events can have severe consequences, including hospitalization, disability, and even death. Accurate and timely assessment of bleeding risk is essential for preventing these complications and improving patient outcomes.

Kribado: Your Partner in Bleeding Risk Management
Revolutionize Bleeding Risk Assessment with Kribado
Kribado is an innovative patient screening solution designed to accurately and efficiently assess the risk of bleeding. By leveraging the HAS-BLED score and advanced algorithms, Kribado empowers healthcare providers to optimize treatment plans and reduce the risk of bleeding complications.
How Kribado Works
- Rapid Bleeding Risk Assessment: Quickly assess patient bleeding risk using the HAS-BLED score.
- Data-Driven Insights: Gain valuable information to tailor treatment plans.
- Improved Patient Outcomes: Reduce the risk of bleeding complications and enhance patient safety.
- Efficient Workflow Integration: Seamlessly integrate bleeding risk assessments into clinical practice.

Indigital Technologies -Trusted by Pharmaceutical Leaders
Indigital Technologies LLP is a proven leader in pharmaceutical business growth. With a strong track record of delivering innovative solutions, we are committed to improving patient care and driving industry progress.